Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-22
2011-03-22
Morris, Patricia L (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07910742
ABSTRACT:
Compounds that inhibit survivin, compositions containing the compounds and methods of treating diseases in which survivin is unregulated or overexpressed are disclosed.
REFERENCES:
Balant et al., “Metabolic Considerations, etc.,”Burger's Medicinal Chemistry, 5th ed., 1, Wolff ed. NY: John Wiley & Sons, 1995, pp. 949-982.
A. Burkle, et al., “Ageing and PARP”,Pharmacological Research, 52: 93-99 (2005).
A. Chiarugi, et al., “Poly(ADP-ribosyl)ation and Stroke”,Pharmacological Research, 52: 15-24 (2005).
S. Cuzzocrea, et al., “Role of Poly(ADP-ribose) Glycohydrolase (PARG) in Shock, Ischemia and Reperfusion”,Pharmacological Research, 52: 100-108 (2005).
S. Cuzzocrea, et al., “Shock, Inflammation and PARP”,Pharmacological Research, 52: 72-82 (2005).
K. Devalaraja-Narashimha, et al. “Poly(ADP-ribose) Polymerase-Medicated Cell Injury in Acute Renal Failure”,Pharmacological Research, 52: 44-59 (2005).
G. Graziani, et al., “Clinical Perspectives of PARP Inhibitors”,Pharmacological Research, 52: 109-118 (2005).
G. Graziani, et al., “PARP-1 Inhibition to Treat Cancer, Ischemia, Inflammation”,Pharmacological Research, 52: 1-4 (2005).
D.W. Koh, et al. “Mediation of Cell Death by Poly (ADP-ribose) Polymerase-1”,Pharmacological Research, 52: 5-14 (2005).
C. Szabo, et al., “Cardioprotective Effects of Poly(ADP-ribose) Polynerase Inhibition”,Pharmacological Research, 52: 34-43 (2005).
C. Szabo, et al., “Roles of Poly(ADP-ribose) Polymerase Activiation in the Pathogenesis of Diabetes Mellitus and its Complications”,Pharmacological Research, 52: 60-71 (2005).
L. Tentori, et al., “Chemopotentiation by PARP Inhibitors in Cancer Therapy”,Pharmacological Research, 52: 25-33 (2005).
L. Virag, et al., “Poly(ADP-ribosyl)ation in Asthma and Other Lung Diseases”,Pharmacological Research, 52: 25-33 (2005).
Elmore Steven W.
Kunzer Aaron R.
Sauer Daryl R.
Sun Chaohong
Wendt Michael D.
Abbott Laboratories
Manzari Oona
Morris Patricia L
LandOfFree
Survivin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Survivin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Survivin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619511